LDS/Medical Tests/Interleukin 2 Receptor Subunit Gamma (IL2RG) Genotyping

Interleukin 2 Receptor Subunit Gamma (IL2RG) Genotyping

The Interleukin 2 Receptor Subunit Gamma (IL2RG) gene is located at Xq13.1 and codes for the gamma protein (gamma C), which is an integral part of several interleukin receptors including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. These receptors are found on the membrane of cells involved in immune regulation, specifically lymphocytes. The gamma C protein is a transmembrane protein consists of an extracellular portion attached to the receptor and an intracellular portion that activates downstream signaling pathways relaying signals to the nucleus. One of the important gamma C-regulated signaling pathways is the Janus Kinase (JAK) pathway.

Importantly, gamma C is also present on the surface of lymphocyte progenitors in the bone marrow. This protein plays a vital role in the differentiation, growth, development, and maturation of the different lymphocyte subtypes: T-cells, B-cells, and natural killer (NK) cells. These cells are an essential component of the immune system of the body with roles in humoral as well as cell-mediated immunity. Mutations in IL2RG may form defective gamma C and impair the maturation of lymphocytes resulting in a form of severe combined immunodeficiency (SCID).

Although SCID is also caused by various other factors involving mutations in a variety of genes, almost 60% of SCID is due to IL2RG gene mutations. It is inherited in an X-linked fashion and therefore primarily affects males while females are carriers and pass the gene to male offspring. Occasionally, females may present with clinical SCID manifestations in cases of X-chromosome inactivation, and those with Turner’s syndrome (XO). In vulnerable males, the disease typically starts to manifest clinically during infancy but may be delayed until childhood. Affected children present with recurrent fever, pneumonia, chronic diarrhea, lymphadenopathy, granulomata, skin infections, recurrent urinary tract infections (UTIs), and sepsis. There occur recurrent infections from bacteria and fungus. Bacterial pathogens include Staphylococcus, Escherichia coli, Klebsiella, and occasionally Burkholderia. Aspergillus and Candida are the commonest invading fungal pathogens. Mutations in the IL2GR gene can be successfully detected by next-generation sequencing (NGS).

  • Aids in the diagnosis of X-linked severe combined immunodeficiency (SCID)
  • Useful in the investigation of recurrent infections and compromised immunity

A positive result indicates the presence of mutations or variants in the IL2GR gene and confirms the diagnosis of X-linked severe combined immunodeficiency (SCID).

A negative result indicates the absence of mutations or variants in the IL2RG gene and rules of the diagnosis of X-linked severe combined immunodeficiency (SCID). However, clinicians should note that however, X-linked could be ruled out, SCID is a result of various factors and other gene mutations are involved.

Negative for mutations analysis (no mutations or pathogenic variants detected)

Whole genome sequencing by next-generation sequencing (NGS), Target sequencing by NGS, Sanger sequencing.

Whole blood, EDTA (Lavender tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 1 month

Alternative specimen: extracted DNA (refrigerated).

SCID panel testing by NGS, Complete blood count (CBC), Differential leukocyte count (DLC), Peripheral blood smear (PBS), bone marrow analysis, HIV Antibody ELISA, IL2RG, JAK3, RAG1, RAG2, DCLRE1C, PRKDC, IL7R, CD3D, CD3E, CD247, PTPRC, CORO1A, ADA, and AK2 gene mutation analysis.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login